Renlund, D G <br/><br/>
A prospective comparison of murine monoclonal CD-3 (OKT3) antibody-based and equine antithymocyte globulin-based rejection prophylaxis in cardiac transplantation. Decreased rejection and less corticosteroid use with OKT3.  [electronic resource] 

 -  Transplantation  Apr 1989 
 - 599-605 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0041-1337 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--therapeutic use<br/>Antigens, Differentiation, T-Lymphocyte--immunology<br/>Antilymphocyte Serum--therapeutic use<br/>Azathioprine--therapeutic use<br/>CD3 Complex<br/>Cyclosporins--therapeutic use<br/>Female<br/>Graft Rejection<br/>Heart Transplantation<br/>Humans<br/>Immunosuppression Therapy--methods<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Receptors, Antigen, T-Cell--immunology<br/>Vincristine--therapeutic use